NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.97% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.54% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 7.04% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 6.31% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.23% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.35% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 4.33% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.87% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.76% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.68% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.52% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.46% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.37% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.21% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.42% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.41% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 2.25% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.92% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.64% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 1.60% |